EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid Pharmaceutical Technology - 02 Jul 2024 EMA fast-tracks review of AstraZeneca’s sipavibart to stop Covid ... More
At request of AstraZeneca, Europe withdraws marketing authorization of COVID vaccine Vaxzevria FiercePharma - 08 May 2024 At request of AstraZeneca, Europe withdraws marketing authorization of COVID vaccine Vaxzevria ... More
European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request The Independent - 08 May 2024 European Medicines Agency pulls authorization for AstraZeneca's COVID shot, at company's request ... More
EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention Pharmafile - 01 Jul 2024 EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention ... More
AstraZeneca's COVID prevention drug application gets EU fast-track assessment Reuters - 30 Jun 2024 AstraZeneca's COVID prevention drug application gets EU fast-track assessment ... More
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca European Medicines Agency | - 13 Nov 2020 EMA receives application for conditional marketing authorisation of COVID-19 Vaccine AstraZeneca ... More
EMA: Benefits of AstraZeneca significantly outweigh side effects Telegrafi - 11 Nov 2024 EMA: Benefits of AstraZeneca significantly outweigh side effects ... More
AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment Yahoo Finance - 01 Jul 2024 AstraZeneca's COVID-19 Prevention Drug For Patients With Weak Immune Systems - European Medicines Agency Accepts Marketing Application Under Accelerated Assessment ... More
EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA Pharmaceutical Technology - 24 Sep 2024 EMA CHMP recommends AstraZeneca’s Fasenra to treat EGPA ... More
AstraZeneca’s Tagrisso combination receives CHMP recommendation for advanced lung cancer PMLiVE - 06 Jun 2024 AstraZeneca’s Tagrisso combination receives CHMP recommendation for advanced lung cancer ... More
Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med MedCity News - 07 Jul 2024 Sanofi & Regeneron Drug Dupixent Gets EMA Approval as the First Biologic COPD Med ... More
EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm BioSpace - 12 Apr 2024 EMA Finds No Link Between GLP-1 Drugs and Suicidal Thoughts, Self-Harm ... More
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine FactCheck.org - 23 May 2024 Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine ... More
Covid-19: EU states to resume AstraZeneca vaccine rollout BBC.com - 18 Mar 2021 Covid-19: EU states to resume AstraZeneca vaccine rollout ... More
EU says 'no evidence' to restrict AstraZeneca jab use FRANCE 24 English - 31 Mar 2021 EU says 'no evidence' to restrict AstraZeneca jab use ... More
EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC Pharmaceutical Technology - 04 Mar 2024 EMA awards double validation for Daiichi Sankyo and AstraZeneca’s cancer ADC ... More
EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' BBC.com - 07 Apr 2021 EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect' ... More
European Medicines Agency: There is no indication that AstraZeneca's vaccine causes blood clots Telegrafi - 25 Oct 2024 European Medicines Agency: There is no indication that AstraZeneca's vaccine causes blood clots ... More
EMA: Women and young people are not at higher risk of developing rare blood clots because of AstraZeneca Telegrafi - 26 Oct 2024 EMA: Women and young people are not at higher risk of developing rare blood clots because of AstraZeneca ... More